CYP2C19*2/ABCB1-C3435T polymorphism and risk of cardiovascular events in coronary artery disease patients on clopidogrel: Is clinical testing helpful?

BACKGROUND: Studies evaluating CYP2C19*2 and ABCB1-C3435T polymorphisms have shown conflicting results. We performed this meta-analysis to evaluate role of clinical testing for these polymorphisms in CAD patients on clopidogrel. METHODS: 19,601 patients from 14 trials were analyzed. The endpoints we...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Singh, Mukesh, Shah, Tejaskumar, Adigopula, Sasikanth, Molnar, Janos, Ahmed, Aziz, Khosla, Sandeep, Arora, Rohit
Materialtyp: Artigo
Språk:Inglês
Publicerad: Elsevier 2012
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3860862/
https://ncbi.nlm.nih.gov/pubmed/22929815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ihj.2012.06.003
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk